Type: Pancreatic cancer
Associate Professor Marina Pajic and her team have identified a molecular pathway that controls communication between pancreatic cancer cells and stromal cells.
A/Prof Griffin will conduct pre-clinical tests of a much needed new combination treatment for patients with advanced pancreatic and bowel cancers.
Researchers will use cutting-edge imaging technology and lab models that mimic pancreatic cancer and watch tumour response to treatment.
Researchers will test a dual treatment approach that targets collagen production in pancreatic cancer tumours.
This project aims to improve treatment by monitoring an individual’s response to immunotherapy.
This innovative research could be a breakthrough in treating pancreatic cancer and improving survival outcomes.
Associate Professor Phoebe Phillips and her team have come up with a new way to target the cells that help the spread of aggressive pancreatic cancer.
This project aims to develop a way to increase the effectiveness of chemotherapy in pancreatic cancer using a dual treatment approach that targets the production of protective tissue in the tumour.
This project aims to develop a tailored treatment approach for pancreatic cancer, providing more effective options and boosting the chances of a good outcome.
If this treatment is shown to be effective, it will provide much-needed hope for patients who receive the devastating diagnosis of pancreatic cancer.